Showing results (31-40 of 42) with videos related to
Sort By:
Pageof 5
Diabetes|January 8, 1998
Paradoxical antidiabetogenic effect of gamma-interferon in DP-BB ratsF Nicoletti, P Zaccone, R Di Marco, et al.Minerva Gastroenterologica E Dietologica|July 2, 2005
Frequency of bcl-2/IgH translocation in patients with non-Hodgkin's lymphoma and chronic hepatitis C virus infectionM Libra, V De Re, A Gloghini, et al.Mechanisms of Ageing and Development|June 8, 2001
Effect of 17-beta estradiol and epidermal growth factor on DNA and RNA labeling in astroglial cells during development, maturation and differentiation in cultureN Marletta, D Licciardello, G F Cormaci, et al.Journal of Clinical Pathology|January 31, 2006
Analysis of G(-174)C IL-6 polymorphism and plasma concentrations of inflammatory markers in patients with type 2 diabetes and peripheral arterial diseaseM Libra, S S Signorelli, Y Bevelacqua, et al.Human Mutation|May 25, 1999
Rapid screening of the LDL receptor point mutation FH-Genoa/Palermo. Mutation in brief no. 238. OnlineG Marino, S Travali, T Reyes, et al.Oncogene|February 12, 2008
Impaired p53 function leads to centrosome amplification, acquired ERalpha phenotypic heterogeneity and distant metastases in breast cancer MCF-7 xenograftsA B D'Assoro, R Busby, I D Acu, et al.Leukemia|September 19, 2008
Targeting the leukemic stem cell: the Holy Grail of leukemia therapyN Misaghian, G Ligresti, L S Steelman, et al.Leukemia|March 14, 2008
Targeting survival cascades induced by activation of Ras/Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways for effective leukemia therapyJ A McCubrey, L S Steelman, S L Abrams, et al.Leukemia|March 14, 2008
Contributions of the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways to leukemiaL S Steelman, S L Abrams, J Whelan, et al.Leukemia|March 26, 2011
Targeting the translational apparatus to improve leukemia therapy: roles of the PI3K/PTEN/Akt/mTOR pathwayA M Martelli, C Evangelisti, W Chappell, et al.Pageof 5